Zhenhui Lu

2.2k total citations · 2 hit papers
59 papers, 1.6k citations indexed

About

Zhenhui Lu is a scholar working on Rheumatology, Molecular Biology and Oncology. According to data from OpenAlex, Zhenhui Lu has authored 59 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Rheumatology, 19 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Zhenhui Lu's work include Osteoarthritis Treatment and Mechanisms (23 papers), Inflammatory mediators and NSAID effects (7 papers) and MicroRNA in disease regulation (4 papers). Zhenhui Lu is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (23 papers), Inflammatory mediators and NSAID effects (7 papers) and MicroRNA in disease regulation (4 papers). Zhenhui Lu collaborates with scholars based in China, United States and Singapore. Zhenhui Lu's co-authors include Li Zheng, Jinmin Zhao, Huayu Wu, Xingchen Yang, Wei Li, Zainen Qin, Sijia Liu, Mingwei He, Yiguan Le and Xiaojing Cheng and has published in prestigious journals such as PLoS ONE, Biomaterials and Advanced Science.

In The Last Decade

Zhenhui Lu

57 papers receiving 1.6k citations

Hit Papers

Collagen-alginate as bioink for three-dimensional (3D) ce... 2017 2026 2020 2023 2017 2024 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenhui Lu China 20 614 365 346 344 193 59 1.6k
Gema Jiménez Spain 23 640 1.0× 276 0.8× 322 0.9× 447 1.3× 230 1.2× 53 1.5k
Elena López‐Ruiz Spain 24 459 0.7× 220 0.6× 320 0.9× 409 1.2× 123 0.6× 52 1.4k
Zhen Yang China 26 484 0.8× 586 1.6× 331 1.0× 448 1.3× 217 1.1× 65 1.7k
Qi Jin China 25 706 1.1× 142 0.4× 331 1.0× 695 2.0× 285 1.5× 97 2.2k
Heng Sun China 22 514 0.8× 534 1.5× 293 0.8× 459 1.3× 133 0.7× 42 1.6k
Yuanjin Xu China 21 1.1k 1.8× 282 0.8× 368 1.1× 617 1.8× 168 0.9× 40 2.1k
Kangkang Zha China 20 649 1.1× 395 1.1× 478 1.4× 403 1.2× 117 0.6× 39 1.9k
Xiaoning Duan China 22 541 0.9× 680 1.9× 497 1.4× 460 1.3× 186 1.0× 43 1.8k
Paolo Giannoni Italy 24 1.0k 1.7× 547 1.5× 545 1.6× 414 1.2× 122 0.6× 67 2.3k

Countries citing papers authored by Zhenhui Lu

Since Specialization
Citations

This map shows the geographic impact of Zhenhui Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenhui Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenhui Lu more than expected).

Fields of papers citing papers by Zhenhui Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenhui Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenhui Lu. The network helps show where Zhenhui Lu may publish in the future.

Co-authorship network of co-authors of Zhenhui Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenhui Lu. A scholar is included among the top collaborators of Zhenhui Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenhui Lu. Zhenhui Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Zhenhui, et al.. (2025). CD155 promotes the advancement of hepatocellular carcinoma by suppressing the p53-mediated ferroptosis via interacting with CD96. Journal of Molecular Medicine. 103(3). 285–299. 1 indexed citations
2.
Lai, Jie, et al.. (2024). Clinical features, immunologic parameter and treatment outcome of Chinese tuberculosis patients with or without DM. Frontiers in Medicine. 11. 1386124–1386124. 1 indexed citations
3.
Zhang, Nan, Yang Xu, Ziyu Xun, et al.. (2024). Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma. Biomarker Research. 12(1). 26–26. 43 indexed citations breakdown →
4.
Hu, Hao, Hanji Huang, Jiaxu Li, et al.. (2023). Injectable collagen hydrogel combines human umbilical cord mesenchymal stem cells to promote endometrial regeneration in rats with thin endometrium. International Journal of Biological Macromolecules. 254(Pt 1). 127591–127591. 6 indexed citations
5.
Qin, Zainen, et al.. (2022). ROS-responsive PPGF nanofiber membrane as a drug delivery system for long-term drug release in attenuation of osteoarthritis. npj Regenerative Medicine. 7(1). 66–66. 33 indexed citations
6.
Zhang, Ge, et al.. (2022). Lenvatinib plus immune checkpoint inhibitors or locoregional therapy in unresectable hepatocellular carcinoma: Lessons learned and moving forwards. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1878(1). 188841–188841. 2 indexed citations
7.
Wang, Yunchao, Xiaobo Yang, Dongxu Wang, et al.. (2022). Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma. Frontiers in Oncology. 12. 785535–785535. 17 indexed citations
8.
Yuan, Peng, Jian Wang, Yubo Zhang, et al.. (2021). MiR-192-5p regulates the proliferation and apoptosis of cholangiocarcinoma cells by activating MEK/ERK pathway. 3 Biotech. 11(2). 99–99. 7 indexed citations
9.
Wu, Jian, Peian Cai, Zhenhui Lu, et al.. (2020). Identification of potential specific biomarkers and key signaling pathways between osteogenic and adipogenic differentiation of hBMSCs for osteoporosis therapy. Journal of Orthopaedic Surgery and Research. 15(1). 437–437. 11 indexed citations
10.
Jiang, Dan, Xiaoliang Xie, Zhenhui Lu, et al.. (2020). Establishment of a Colorectal Cancer-Related MicroRNA-mRNA Regulatory Network by Microarray and Bioinformatics. Frontiers in Genetics. 11. 560186–560186. 18 indexed citations
11.
He, Yi, En Ren, Zhenhui Lu, et al.. (2020). Rational engineering of ferritin nanocages for targeted therapy of osteoarthritis. Nanomedicine Nanotechnology Biology and Medicine. 28. 102210–102210. 23 indexed citations
12.
Lu, Zhenhui, Qian Liu, Tongmeng Jiang, et al.. (2020). Injectable calcium phosphate ceramics prevent osteoclastic differentiation and osteoporotic bone loss: Potential applications for regional osteolysis. Materials Science and Engineering C. 110. 110691–110691. 9 indexed citations
13.
Zheng, Li, Sijia Liu, Xiaojing Cheng, et al.. (2019). Intensified Stiffness and Photodynamic Provocation in a Collagen‐Based Composite Hydrogel Drive Chondrogenesis. Advanced Science. 6(16). 1900099–1900099. 105 indexed citations
14.
Sun, Miao, Zhenhui Lu, Peian Cai, Li Zheng, & Jinmin Zhao. (2019). Salidroside enhances proliferation and maintains phenotype of articular chondrocytes for autologous chondrocyte implantation (ACI) via TGF-β/Smad3 Signal. Biomedicine & Pharmacotherapy. 122. 109388–109388. 19 indexed citations
15.
Lu, Zhenhui, Sijia Liu, Yiguan Le, et al.. (2019). An injectable collagen-genipin-carbon dot hydrogel combined with photodynamic therapy to enhance chondrogenesis. Biomaterials. 218. 119190–119190. 165 indexed citations
16.
Lu, Zhenhui, Danqing Lei, Tongmeng Jiang, et al.. (2017). Nerve growth factor from Chinese cobra venom stimulates chondrogenic differentiation of mesenchymal stem cells. Cell Death and Disease. 8(5). e2801–e2801. 34 indexed citations
17.
Yang, Xingchen, Zhenhui Lu, Huayu Wu, et al.. (2017). Collagen-alginate as bioink for three-dimensional (3D) cell printing based cartilage tissue engineering. Materials Science and Engineering C. 83. 195–201. 419 indexed citations breakdown →
18.
Lu, Zhenhui, Liqin Wang, Xiao Lin, et al.. (2015). Stimulating Effect of a Newly Synthesized Sulfonamido-Basedgallate on Articular Chondrocytes in Vitro. Cellular Physiology and Biochemistry. 37(3). 1196–1209. 2 indexed citations
19.
Yang, Min, Xiaoyan Liu, Qing Liu, et al.. (2015). C-reactive protein is a biomarker of AFP-negative HBV-related hepatocellular carcinoma. International Journal of Oncology. 47(2). 543–554. 44 indexed citations
20.
Lu, Zhenhui, et al.. (2012). Overexpression of the B-type Eph and ephrin genes correlates with progression and pain in human pancreatic cancer. Oncology Letters. 3(6). 1207–1212. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026